FDA approves Vizimpro for first-line treatment of metastatic NSCLC with EGFR mutations Sep. 28, 2018 No Comments
FDA grants approval for Copiktra for CLL/SLL, accelerated approval in follicular lymphoma Sep. 25, 2018 No Comments
Xospata approved in Japan for FLT3 mutation-positive relapsed or refractory AML Sep. 25, 2018 No Comments
Eybelis granted marketing approval for glaucoma and ocular hypertension in Japan Sep. 25, 2018 No Comments
Hulio, a biosimilar to adalimumab, receives marketing authorization in Europe Sep. 21, 2018 No Comments